Oarsman Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $293K | Buy |
+2,279
| New | +$267K | 0.03% | 193 |
|
|
2025
Q1 | – | Sell |
-2,365
| Closed | -$235K | – | 609 |
|
|
2024
Q4 | $235K | Sell |
2,365
-422
| -15% | -$43.5K | 0.04% | 210 |
|
|
2024
Q3 | $316K | Buy |
2,787
+286
| +11% | +$34K | 0.06% | 178 |
|
|
2024
Q2 | $310K | Buy |
2,501
+231
| +10% | +$29.8K | 0.07% | 172 |
|
|
2024
Q1 | $300K | Buy |
2,270
+116
| +5% | +$14.3K | 0.07% | 168 |
|
|
2023
Q4 | $235K | Buy |
+2,154
| New | +$224K | 0.06% | 206 |
|
|
2022
Q2 | – | Sell |
-2,682
| Closed | -$220K | – | 184 |
|
|
2022
Q1 | $220K | Buy |
+2,682
| New | +$211K | 0.09% | 175 |
|
|
2021
Q4 | – | Sell |
-3,237
| Closed | -$243K | – | 189 |
|
|
2021
Q3 | $243K | Hold |
3,237
| – | – | 0.1% | 164 |
|
|
2021
Q2 | $252K | Sell |
3,237
-155
| -5% | -$11.5K | 0.1% | 164 |
|
|
2021
Q1 | $250K | Sell |
3,392
-53
| -2% | -$3.91K | 0.11% | 158 |
|
|
2020
Q4 | $269K | Buy |
3,445
+11
| +0.3% | +$841 | 0.1% | 148 |
|
|
2020
Q3 | $272K | Sell |
3,434
-6
| -0.2% | -$470 | 0.12% | 134 |
|
|
2020
Q2 | $254K | Buy |
+3,440
| New | +$259K | 0.13% | 135 |
|
|
2020
Q1 | – | Sell |
-3,650
| Closed | -$317K | – | 159 |
|
|
2019
Q4 | $317K | Buy |
3,650
+135
| +4% | +$11.1K | 0.14% | 136 |
|
|
2019
Q3 | $282K | Buy |
3,515
+121
| +4% | +$9.7K | 0.13% | 149 |
|
|
2019
Q2 | $272K | Sell |
3,394
-21
| -0.6% | -$1.61K | 0.12% | 154 |
|
|
2019
Q1 | $271K | Sell |
3,415
-53
| -2% | -$3.96K | 0.13% | 153 |
|
|
2018
Q4 | $253K | Sell |
3,468
-110
| -3% | -$7.76K | 0.13% | 151 |
|
|
2018
Q3 | $242K | Hold |
3,578
| – | – | 0.1% | 164 |
|
|
2018
Q2 | $207K | Buy |
+3,578
| New | +$202K | 0.09% | 169 |
|
|
2017
Q4 | – | Sell |
-3,576
| Closed | -$218K | – | 194 |
|
|
2017
Q3 | $218K | Hold |
3,576
| – | – | 0.09% | 173 |
|
|
2017
Q2 | $219K | Hold |
3,576
| – | – | 0.1% | 171 |
|
|
2017
Q1 | $217K | Buy |
+3,576
| New | +$217K | 0.1% | 170 |
|
|
2016
Q4 | – | Sell |
-3,576
| Closed | -$213K | – | 169 |
|
|
2016
Q3 | $213K | Sell |
3,576
-84
| -2% | -$4.91K | 0.11% | 173 |
|
|
2016
Q2 | $201K | Buy |
+3,660
| New | +$195K | 0.1% | 178 |
|
|
2013
Q4 | – | Sell |
-4,713
| Closed | -$214K | – | 158 |
|
|
2013
Q3 | $214K | Hold |
4,713
| – | – | 0.19% | 134 |
|
|
2013
Q2 | $209K | Buy |
+4,713
| New | +$211K | 0.2% | 128 |
|
Other funds holding MRK
Oarsman Capital's MRK Position: Q2 2026 in Review
Oarsman Capital opened a new position in Merck (MRK) in Q2 2026: 2,279 shares worth $293K. The stake represents 0.03% of the portfolio and ranks #193 among its holdings. This is a return to the name: Oarsman Capital previously reported a position in MRK as recently as Q4 2024.
Oarsman Capital first reported a position in MRK in Q2 2013 and has held it in 27 quarters since. The position peaked at $317K in Q4 2019. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Oarsman Capital held 2,279 shares of Merck worth $293K as of Q2 2026.
- Merck was a new Oarsman Capital position in Q2 2026.
- Merck made up 0.03% of Oarsman Capital's portfolio in Q2 2026, its #193 holding.
- Oarsman Capital first reported a position in Merck in Q2 2013 and has held it in 27 quarters since.
- Oarsman Capital's Merck position peaked at $317K in Q4 2019.
- 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Oarsman Capital's 13F filing for Q2 2026, filed 7 Aug 2026.